Found: 19
Select item for more details and to access through your institution.
Rationale and design of phase II clinical trial of dual inhibition with ramucirumab and erlotinib in EGFR exon 19 deletion-positive treatment-naïve non-small cell lung cancer with high PD-L1 expression (SPIRAL-3D study).
- Published in:
- Therapeutic Advances in Medical Oncology, 2023, p. 1, doi. 10.1177/17588359231177022
- By:
- Publication type:
- Article
Comparison of computed tomography imaging analyses for evaluation after chemotherapy in patients with colorectal cancer: a retrospective pooled analysis of six phase II clinical trials.
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 11, p. 1397, doi. 10.1007/s10147-019-01509-8
- By:
- Publication type:
- Article
Skeletal muscle loss during systemic chemotherapy for colorectal cancer indicates treatment response: a pooled analysis of a multicenter clinical trial (KSCC 1605-A).
- Published in:
- International Journal of Clinical Oncology, 2019, v. 24, n. 10, p. 1204, doi. 10.1007/s10147-019-01460-8
- By:
- Publication type:
- Article
A prospective study of XELIRI plus bevacizumab as a first-line therapy in Japanese patients with unresectable or recurrent colorectal cancer (KSCC1101).
- Published in:
- International Journal of Clinical Oncology, 2017, v. 22, n. 5, p. 913, doi. 10.1007/s10147-017-1140-z
- By:
- Publication type:
- Article
Current state of yusho and prospects for therapeutic strategies.
- Published in:
- Environmental Science & Pollution Research, 2018, v. 25, n. 17, p. 16472, doi. 10.1007/s11356-017-0833-1
- By:
- Publication type:
- Article
Phase II study of durvalumab (MEDI 4736) plus carboplatin and etoposide in elderly patients with extensive stage small cell lung cancer: Study protocol of turtle study (LOGIK 2003).
- Published in:
- Thoracic Cancer, 2023, v. 14, n. 1, p. 105, doi. 10.1111/1759-7714.14727
- By:
- Publication type:
- Article
A phase I/II study of S-1 and irinotecan (IRIS) combined with cetuximab in patients with RAS wild-type metastatic colorectal cancer (KSCC1401).
- Published in:
- Cancer Chemotherapy & Pharmacology, 2020, v. 86, n. 2, p. 285, doi. 10.1007/s00280-020-04108-x
- By:
- Publication type:
- Article
Clarithromycin Plus Intravenous Immunoglobulin Therapy Can Reduce the Relapse Rate of Kawasaki Disease: A Phase 2, Open-Label, Randomized Control Study.
- Published in:
- Journal of the American Heart Association, 2017, v. 6, n. 7, p. 1, doi. 10.1161/JAHA.116.005370
- By:
- Publication type:
- Article
Cessation of nilotinib in patients with chronic myelogenous leukemia who have maintained deep molecular responses for 2 years: a multicenter phase 2 trial, stop nilotinib (NILSt).
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of switching to nilotinib in patients with CML-CP in major molecular response to imatinib: results of a multicenter phase II trial (NILSw trial).
- Published in:
- 2018
- By:
- Publication type:
- journal article
Forthcoming Phase II Study of Durvalumab (MEDI4736) Plus Chemotherapy for Small Cell Lung Cancer with Brain Metastases.
- Published in:
- Cancer Management & Research, 2022, v. 14, p. 3449, doi. 10.2147/CMAR.S391220
- By:
- Publication type:
- Article
Longitudinal monitoring of somatic genetic alterations in circulating cell-free DNA during treatment with epidermal growth factor receptor-tyrosine kinase inhibitors.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Phase II study of carboplatin/nab-paclitaxel/atezolizumab combination therapy for advanced nonsquamous non-small cell lung cancer patients with impaired renal function: RESTART trial.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Prophylactic Effect of Dexamethasone on Regorafenib-Related Fatigue and/or Malaise: A Randomized, Placebo-Controlled, Double-Blind Clinical Study in Patients with Unresectable Metastatic Colorectal Cancer (KSCC1402/HGCSG1402).
- Published in:
- Oncology, 2018, v. 94, n. 5, p. 289, doi. 10.1159/000486624
- By:
- Publication type:
- Article
Phase II Trial on Osimertinib as a First-Line Treatment for EGFR Mutation-Positive Advanced NSCLC in Elderly Patients: The SPIRAL-0 Study.
- Published in:
- Oncologist, 2022, v. 27, n. 11, p. 903, doi. 10.1093/oncolo/oyac193
- By:
- Publication type:
- Article
Erlotinib for Non‐Small Cell Lung Cancer with Leptomeningeal Metastases: A Phase II Study (LOGIK1101).
- Published in:
- Oncologist, 2020, v. 25, n. 12, p. e1869, doi. 10.1634/theoncologist.2020-0640
- By:
- Publication type:
- Article
Survival Analysis for Patients with ALK Rearrangement‐Positive Non‐Small Cell Lung Cancer and a Poor Performance Status Treated with Alectinib: Updated Results of Lung Oncology Group in Kyushu 1401.
- Published in:
- Oncologist, 2020, v. 25, n. 4, p. 306, doi. 10.1634/theoncologist.2019-0728
- By:
- Publication type:
- Article
Exploration of resistance mechanisms for epidermal growth factor receptor‐tyrosine kinase inhibitors based on plasma analysis by digital polymerase chain reaction and next‐generation sequencing.
- Published in:
- Cancer Science, 2018, v. 109, n. 12, p. 3921, doi. 10.1111/cas.13820
- By:
- Publication type:
- Article
Expression of the anaphylatoxin C5a receptor in gastric cancer: implications for vascular invasion and patient outcomes.
- Published in:
- Medical Oncology, 2016, v. 33, n. 11, p. 1, doi. 10.1007/s12032-016-0834-9
- By:
- Publication type:
- Article